Technology

In its 16 October 2026 list of long-term suspended entities, ASX recorded the company's full-year accounts due on 30 September 2026 as outstanding. The notice set 30 September 2027 as the deadline to lodge overdue reports and 1 October 2027 as the deadline to …

Two days earlier, the company announced an early-stage collaboration with global photonics group Coherent to assess a novel GaN-based device for scientific and medical applications, adding to a run of customer-funded development programmes.

The ruling covers about A$5.5 million in total: a payment made in November 2025, equal to about 12 cents per share after a 100-for-1 share consolidation, and a A$0.2111 per share return paid on 7 August 2026 followingShareholderapproval at a July extraordinary general meeting. …

He will lead quantum commercialisation and hardware development, with a remit to grow the Australian customer pipeline, deepen the company'sPartnershipwith IonQ and advance next-generation graphene-based qubit hardware.

The agreement runs for an initial three years and renews automatically for one-year periods unless terminated. No contract value was attached, as commercial commitments arise only once the parties document specific opportunities and enter customer and subcontracting arrangements.

The update follows a solid FY26, in which revenue grew and losses shrank, and a period of board renewal ahead of the company'sAnnual General Meetingin Sydney on 17 November 2026.

The cohort is the firstTrancheof a 283-university portfolio covered by a platform agreement announced in April 2026, giving IODM its initial foothold in a market far larger than its established UK base.